Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 15, 2011 (Vol. 31, No. 18)

Target-Enrichment Field Continuing to Expand

Cost Advantages Over Whole-Genome Sequencing Likely Main Factor in Growth

  • As a result of recent progress in DNA sequencing technologies, which has generated datasets of unprecedented complexity and advanced our understanding of health, disease, and development, whole-genome sequencing has emerged as a highly anticipated goal. However, routine sequencing of whole genomes is still a challenging milestone, particularly for clinical ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.